HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.

Abstract
Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF V600E mutation was identified in approximately 20 % of gangliogliomas. Here, we analyzed a total of 71 gangliogliomas for BRAF V600E mutational status by VE1 immunohistochemistry and direct DNA sequencing. The BRAF V600E mutation was detected in 41/71 (58 %) gangliogliomas by immunohistochemistry. DNA sequencing was concordant in 60 of 62 analyzed cases. BRAF status was compared with clinical, histological and immunohistochemical data. Presence of the BRAF V600E mutation was associated with expression of synaptophysin in the tumor (p = 0.0008), presence of dysplastic neurons (p = 0.011) and lymphocytic cuffs (p = 0.018), and with younger age (p = 0.0054). Extensive hemosiderin deposition within the tumor was significantly associated with BRAF wild-type status (p = 0.042). No significant association was found with proliferation (p = 0.053), presence of phospho ERK (p = 0.1) or senescence marker p16(INK4a) (p = 0.22). Using VE1, we localized the BRAF V600E-mutated protein predominantly to the neuronal compartment, indicating that BRAF mutations occur in cells that have the capacity to differentiate into ganglionic cells. In many cases mutant BRAF is additionally expressed by the glial compartment, indicating that in these cases the cell targeted by BRAF mutation was likely capable of differentiating along both the ganglionic and glial lineages. No cases with an exclusive expression of BRAF V600E in the glial compartment were observed. Thus, using VE1 we identified the neuronal compartment as an essential part of this mixed glioneuronal tumor.
AuthorsChristian Koelsche, Adelheid Wöhrer, Astrid Jeibmann, Jens Schittenhelm, Genevieve Schindler, Matthias Preusser, Felix Lasitschka, Andreas von Deimling, David Capper
JournalActa neuropathologica (Acta Neuropathol) Vol. 125 Issue 6 Pg. 891-900 (Jun 2013) ISSN: 1432-0533 [Electronic] Germany
PMID23435618 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Mutant Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Brain Neoplasms (genetics, metabolism, pathology)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Feasibility Studies
  • Female
  • Ganglioglioma (genetics, metabolism, pathology)
  • Humans
  • Male
  • Middle Aged
  • Mutant Proteins (metabolism)
  • Mutation (physiology)
  • Proto-Oncogene Proteins B-raf (genetics, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: